Search Results
Caribou Biosciences CRBU Q1 2023 Earnings Presentation
Caribou Biosciences (CRBU): Q2 2023 earnings. Predictable and steady. Blue-chip in the making.
Is it time to buy CRBU? Caribou Biosciences' CB-011 CAR-T Granted Fast Track Designation by FDA
Can We Combine the Power of CRISPR and CAR-T to Fight CANCER? Caribou (#CRBU) is Doing Just that!!!
Pfizers Carbon GeneEdited Cancer Treatment Surges CRBU Stock
The Promise of Genome Editing with Caribou Biosciences' Rachel Haurwitz, Ph.D.
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
CRISPR Earnings UPDATE! (CRSP Stock, VERV, BEAM and beyond)
Gene Editing Stocks Are Set to Explode. Here's Why.
Editas Medicine: Earnings beat, sharp focus on spending and cash runway to 2025 - Earnings review.
Twist Bioscience Stock Stung by Short Report
Q2 2022 Earnings estimate for Pacific Biosciences (PACB)
